Targeted Cardiac Overexpression of A20 Improves Left Ventricular Performance and Reduces Compensatory Hypertrophy After Myocardial Infarction

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Circulation

• Publication date

  2007-04-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.106.656835PMID 17389268
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A20 inhibits oxidized low‐density lipoprotein‐induced apoptosis through negative Fas/Fas ligand‐dependent activation of caspase‐8 and mitochondrial pathways in murine RAW264.7 macrophages

  2006cited by this paper
• Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1.

  2006cited by this paper
• Blockade of NF-κB improves cardiac function and survival after myocardial infarction

  2006cited by this paper
• Blockade of NF-kappaB improves cardiac function and survival after myocardial infarction.

  2006cited by this paper
• Absence of NF-kappaB subunit p50 improves heart failure after myocardial infarction.

  2006cited by this paper
• Apoptosis of ventricular myocytes: a means to an end.

  2005cited by this paper
• Mitochondria and Ischemia/Reperfusion Injury

  2005cited by this paper
• Targeting survival signaling in heart failure.

  2005cited by this paper
• A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions.

  2005cited by this paper
• A20 inhibits NF-κB activation by dual ubiquitin-editing functions

  2005cited by this paper
• Chronic Production of Angiotensin IV in the Brain Leads to Hypertension That Is Reversible With an Angiotensin II AT1 Receptor Antagonist

  2004cited by this paper
• Excessive Tumor Necrosis Factor Activation After Infarction Contributes to Susceptibility of Myocardial Rupture and Left Ventricular Dysfunction

  2004cited by this paper
• Inflammatory cytokines and postmyocardial infarction remodeling.

  2004cited by this paper
• Inhibition of the activation of nuclear factor kappa B to reduce myocardial reperfusion injury and infarct size.

  2004cited by this paper
• Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure

  2003cited by this paper
• A20 Is Dynamically Regulated in the Heart and Inhibits the Hypertrophic Response

  2003cited by this paper
• Role of the mitochondrial permeability transition in myocardial disease.

  2003cited by this paper
• Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction.

  2003cited by this paper
• Signal transduction by tumor necrosis factor and its relatives.

  2001cited by this paper
• Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-kappaB activation and alleviates myocardial ischemia/reperfusion injury.

  2001cited by this paper
• Calcineurin, mitochondrial membrane potential, and cardiomyocyte apoptosis.

  2001cited by this paper
• A direct requirement of nuclear factor-κB for suppression of apoptosis in ventricular myocytes

  2000cited by this paper
• A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis.

  2000cited by this paper
• A direct requirement of nuclear factor-kappa B for suppression of apoptosis in ventricular myocytes.

  2000cited by this paper
• In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction

  1997cited by this paper
• Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits.

  1996cited by this paper
• Nuclear Factor- (cid:1) B Protects the Adult Cardiac Myocyte Against Ischemia-Induced Apoptosis in a Murine Model of Acute Myocardial Infarction

  year unknowncited by this paper
• The FASEB Journal • FJ Express Full-Length Article Absence of NF-�B subunit p50 improves heart failure after myocardial infarction

  year unknowncited by this paper

• Association of serum A20 levels with stroke-associated pneumonia, early neurological deterioration, and poor neurological prognosis following acute supratentorial intracerebral hemorrhage: a prospective cohort study

  2025cites this paper
• OTUD1 deficiency attenuates myocardial ischemia/reperfusion induced cardiomyocyte apoptosis by regulating RACK1 phosphorylation

  2025cites this paper
• Deubiquitinase USP25 Alleviates Obesity-Induced Cardiac Remodeling and Dysfunction by Downregulating TAK1 and Reducing TAK1-Mediated Inflammation

  2024cites this paper
• Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities

  2024cites this paper
• Interval training suppresses nod-like receptor protein 3 inflammasome activation to improve cardiac function in myocardial infarction rats by hindering the activation of the transforming growth factor-β1 pathway

  2024cites this paper
• OTUD1 promotes pathological cardiac remodeling and heart failure by targeting STAT3 in cardiomyocytes

  2023cites this paper
• Astragaloside IV derivative HHQ16 ameliorates infarction-induced hypertrophy and heart failure through degradation of lncRNA4012/9456

  2023cites this paper
• MOF-derived bimetallic nanozyme to catalyze ROS scavenging for protection of myocardial injury

  2023cites this paper
• Edgeworthia gardneri (Wall.) Meisn. extract protects against myocardial infarction by inhibiting NF-κB-and MAPK-mediated endothelial inflammation

  2022cites this paper
• Exercise Training Alleviates Cardiac Fibrosis through Increasing Fibroblast Growth Factor 21 and Regulating TGF-β1-Smad2/3-MMP2/9 Signaling in Mice with Myocardial Infarction

  2021cites this paper
• Association of NOD1, NOD2, PYDC1 and PYDC2 genes with Behcet’s disease susceptibility and clinical manifestations

  2021cites this paper
• Role of Muscle-Specific Histone Methyltransferase (Smyd1) in Exercise-Induced Cardioprotection against Pathological Remodeling after Myocardial Infarction

  2020cites this paper
• Cellular Protein Quality Control in Diabetic Cardiomyopathy: From Bench to Bedside

  2020influential citation
• Polycystin-1, AKT, and CTGF during ischemia/reperfusion.

  2020cites this paper
• Chemokines in Myocardial Infarction

  2020cites this paper
• CYLD exaggerates pressure overload-induced cardiomyopathy via suppressing autolysosome efflux in cardiomyocytes.

  2020cites this paper
• The role of CD27-CD70 signaling in myocardial infarction and cardiac remodeling.

  2019cites this paper
• Molecular tissue changes in early myocardial ischemia: from pathophysiology to the identification of new diagnostic markers

  2018cites this paper
• Heat‐shock transcription factor 1 is critically involved in the ischaemia‐induced cardiac hypertrophy via JAK2/STAT3 pathway

  2018cites this paper
• Therapeutic Targets for Treatment of Heart Failure: Focus on GRKs and β-Arrestins Affecting βAR Signaling

  2018cites this paper
• The role of K63‐linked polyubiquitination in cardiac hypertrophy

  2018cites this paper
• Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and Challenges.

  2017cites this paper
• Sequence variation in PPP1R13L results in a novel form of cardio‐cutaneous syndrome

  2017cites this paper
• M2b macrophages reduce early reperfusion injury after myocardial ischemia in mice: A predominant role of inhibiting apoptosis via A20.

  2017cites this paper
• Post-infarct sleep disruption and its relation to cardiac remodeling in a rat model of myocardial infarction

  2017cites this paper
• Recombinant frizzled1 protein attenuated cardiac hypertrophy after myocardial infarction via the canonical Wnt signaling pathway

  2017cites this paper
• The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis

  2017cites this paper
• Sequence variation in PPP1R13L results in a novel form of cardio‐cutaneous syndrome

  2017cites this paper
• Reprogramming Innate Immune Signaling in Cardiometabolic Disease

  2017cites this paper
• Circulating Long Noncoding RNA HOTAIR is an Essential Mediator of Acute Myocardial Infarction

  2017cites this paper
• Transcriptional and post-transcriptional regulation of Nrf2 in the heart by the deubiquitinase CYLD

  2016cites this paper
• The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.

  2016cites this paper
• Anti-inflammatory and anti-osteoclastogenic effects of zinc finger protein A20 overexpression in human periodontal ligament cells.

  2016cites this paper
• Increased mortality and aggravation of heart failure in liver X receptor-α knockout mice after myocardial infarction

  2016cites this paper
• Upregulation of neuronal zinc finger protein A20 expression is required for electroacupuncture to attenuate the cerebral inflammatory injury mediated by the nuclear factor-kB signaling pathway in cerebral ischemia/reperfusion rats

  2016cites this paper
• MCP-1-induced protein attenuates post-infarct cardiac remodeling and dysfunction through mitigating NF-κB activation and suppressing inflammation-associated microRNA expression

  2015cites this paper
• Interferon Regulatory Factor Signalings in Cardiometabolic Diseases

  2015cites this paper
• Vinexin-β exacerbates cardiac dysfunction post-myocardial infarction via mediating apoptotic and inflammatory responses.

  2015cites this paper
• Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.

  2015cites this paper
• Regulatory role of CARD3 in left ventricular remodelling and dysfunction after myocardial infarction

  2015cites this paper
• Novel Role for Caspase-Activated DNase in the Regulation of Pathological Cardiac Hypertrophy

  2015cites this paper
• ALK7 protects against pathological cardiac hypertrophy in mice.

  2015cites this paper
• Dickkopf-3 protects against cardiac dysfunction and ventricular remodelling following myocardial infarction

  2015cites this paper
• Cardioprotective role of growth/differentiation factor 1 in post‐infarction left ventricular remodelling and dysfunction

  2015cites this paper
• IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling

  2014cites this paper
• The transcription factor DREAM represses A20 and mediates inflammation

  2014cites this paper
• Interferon regulatory factor 9 is an essential mediator of heart dysfunction and cell death following myocardial ischemia/reperfusion injury

  2014cites this paper
• Disruption of Tumor Necrosis Factor Receptor Associated Factor 5 Exacerbates Pressure Overload Cardiac Hypertrophy and Fibrosis

  2014cites this paper
• Overexpression of Mitofilin in the Mouse Heart Promotes Cardiac Hypertrophy in Response to Hypertrophic Stimuli

  2014cites this paper
• Ubiquitin Carboxyl Terminal Hydrolyase L1 -Suppressed Autophagic Degradation of p21WAF1/Cip1 as a Novel Feedback Mechanism in the Control of Cardiac Fibroblast Proliferation

  2014cites this paper
• Overexpression of a dominant-negative mutant of SIRT1 in mouse heart causes cardiomyocyte apoptosis and early-onset heart failure

  2014cites this paper
• Regulator of G Protein Signaling 3 Protects Against Cardiac Hypertrophy in Mice

  2014cites this paper
• Translational studies of A20 in atherosclerosis and cardiovascular disease.

  2014cites this paper
• Emerging roles for A20 in islet biology and pathology.

  2014cites this paper
• Signal Regulatory Protein-&agr; Protects Against Cardiac Hypertrophy Via the Disruption of Toll-Like Receptor 4 Signaling

  2014cites this paper
• Dickkopf-3 attenuates pressure overload-induced cardiac remodelling.

  2014cites this paper
• Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction.

  2014cites this paper
• Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy

  2013cites this paper
• SIRT1 mediates the protective function of Nkx2.5 during stress in cardiomyocytes

  2013cites this paper
• β-arrestin2 in Infiltrated Macrophages Inhibits Excessive Inflammation after Myocardial Infarction

  2013cites this paper
• Vinexin-β protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway

  2013cites this paper
• Negative Regulators of Inflammation as Endogenous Protective Mechanisms in Postinfarction Remodeling

  2013cites this paper
• Comparative Antiapoptotic Effects of KB-R7943 and Ischemic Postconditioning During Myocardial Ischemia Reperfusion

  2012cites this paper
• Inflammation, Endoplasmic Reticulum Stress, Autophagy, and the Monocyte Chemoattractant Protein-1/CCR2 Pathway

  2012cites this paper
• Disruption of mindin exacerbates cardiac hypertrophy and fibrosis

  2012cites this paper
• A20 (TNFAIP3) Alleviates CVB3-Induced Myocarditis via Inhibiting NF-κB Signaling

  2012cites this paper
• Inhibition of XO or NOX attenuates diethylstilbestrol-induced endothelial nitric oxide deficiency without affecting its effects on LNCaP cell invasion and apoptosis.

  2012cites this paper
• In vivo delivery of nucleic acids via glycopolymer vehicles affords therapeutic infarct size reduction in vivo.

  2012cites this paper
• Anti-apoptosis and cell survival: a review.

  2011cites this paper
• Variants of tumor necrosis factor-induced protein 3 gene are associated with left ventricular hypertrophy in hypertensive patients.

  2011cites this paper
• Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species‐dependent ERK1/2 signalling

  2010cites this paper
• Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR‐dependent signaling

  2010cites this paper
• Puerarin attenuates high-glucose-and diabetes-induced vascular smooth muscle cell proliferation by blocking PKCbeta2/Rac1-dependent signaling.

  2010cites this paper
• Ca2+ influx via TRPC channels induces NF-kappaB-dependent A20 expression to prevent thrombin-induced apoptosis in endothelial cells.

  2010cites this paper
• Practical prevention of cardiac remodeling and atrial fibrillation with full-spectrum antioxidant therapy and ancillary strategies.

  2010cites this paper
• Ca influx via TRPC channels induces NF- (cid:2) B-dependent A20 expression to prevent thrombin-induced apoptosis in endothelial cells

  2010cites this paper
• Tumor Suppressor A20 Protects Against Cardiac Hypertrophy and Fibrosis by Blocking Transforming Growth Factor-&bgr;–Activated Kinase 1–Dependent Signaling

  2010cites this paper
• Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload

  2010cites this paper
• Role of nuclear factor kappaB in cardiovascular health and disease.

  2010cites this paper
• Breviscapine protects against cardiac hypertrophy through blocking PKC‐α‐dependent signaling

  2010cites this paper
• Chloride Channel 2 and Protein Kinase C Epsilon Protein Module in Ischemic Preconditioning of Rabbit Cardiomyocytes

  2010cites this paper
• RESEARCH PAPER Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent

  2010cites this paper
• Cellular FLICE-Inhibitory Protein Protects Against Cardiac Remodeling Induced by Angiotensin II in Mice

  2010cites this paper
• A20 suppresses inflammatory responses and bone destruction in human fibroblast-like synoviocytes and in mice with collagen-induced arthritis.

  2010cites this paper
• The role of deubiquitinating enzymes in apoptosis

  2010influential citation
• Synergistic effects of sonoporation and taurolidin/TRAIL on apoptosis in human fibrosarcoma.

  2010cites this paper
• A20 is an early responding negative regulator of Toll‐like receptor 5 signalling in intestinal epithelial cells during inflammation

  2010cites this paper
• influx via TRPC channels induces NF-B-dependent A 20 expression to prevent thrombin-induced apoptosis in endothelial cells

  2010cites this paper
• This information is current as Inflammation in Mice A 20 Attenuates Allergic Airway

  2009cites this paper
• Survival and Cardiac Remodeling After Myocardial Infarction Are Critically Dependent on the Host Innate Immune Interleukin-1 Receptor–Associated Kinase-4 Signaling: A Regulator of Bone Marrow–Derived Dendritic Cells

  2009cites this paper
• A 20 Attenuates Allergic Airway Inflammation in Mice 1

  2009cites this paper
• Transient Receptor Potential Vanilloid Gene Deletion Exacerbates Inflammation and Atypical Cardiac Remodeling After Myocardial Infarction

  2009cites this paper
• Other Transgenic Animal Models Used in Cardiovascular Studies

  2009cites this paper
• Targeting the Heart Using in vivo Phage Display

  2009cites this paper
• Targeted Expression of Receptor-Associated Late Transducer Inhibits Maladaptive Hypertrophy via Blocking Epidermal Growth Factor Receptor Signaling

  2009cites this paper
• A20 Attenuates Allergic Airway Inflammation in Mice1

  2009cites this paper
• Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart.

  2009cites this paper
• Transgenic expression of the human A20 gene in cloned pigs provides protection against apoptotic and inflammatory stimuli

  2009cites this paper
• Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction.

  2009cites this paper
• Pretreatment with B-type natriuretic peptide protects the heart from ischemia-reperfusion injury by inhibiting myocardial apoptosis.

  2009cites this paper